DTIL Precision Biosciences Inc

Price (delayed)

$9.39

Market cap

$539.74M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.9

Enterprise value

$356.34M

Sector: Healthcare
Industry: Biotechnology

Highlights

Precision Biosciences's revenue has increased by 41% YoY and by 39% from the previous quarter
Precision Biosciences's gross profit has increased by 41% YoY and by 39% from the previous quarter
Precision Biosciences's quick ratio has decreased by 50% YoY but it has increased by 43% QoQ
The company's equity fell by 49% YoY but it rose by 32% QoQ

Key stats

What are the main financial stats of DTIL
Market
Shares outstanding
57.48M
Market cap
$539.74M
Enterprise value
$356.34M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
9.1
Price to sales (P/S)
15.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.59
Earnings
Revenue
$33.64M
EBIT
-$100.86M
EBITDA
-$90.97M
Free cash flow
$1.54M
Per share
EPS
-$1.9
Free cash flow per share
$0.03
Book value per share
$1.03
Revenue per share
$0.59
TBVPS
$4.61
Balance sheet
Total assets
$262.32M
Total liabilities
$203.49M
Debt
$10.06M
Equity
$58.82M
Working capital
$155.34M
Liquidity
Debt to equity
0.17
Current ratio
3.43
Quick ratio
3.33
Net debt/EBITDA
2.02
Margins
EBITDA margin
-270.5%
Gross margin
100%
Net margin
-299.9%
Operating margin
-300.5%
Efficiency
Return on assets
-52.7%
Return on equity
-159.7%
Return on invested capital
-383.9%
Return on capital employed
-50.8%
Return on sales
-299.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DTIL stock price

How has the Precision Biosciences stock price performed over time
Intraday
-1.16%
1 week
16.36%
1 month
7.07%
1 year
20.54%
YTD
12.59%
QTD
-9.28%

Financial performance

How have Precision Biosciences's revenue and profit performed over time
Revenue
$33.64M
Gross profit
$33.64M
Operating income
-$101.07M
Net income
-$100.86M
Gross margin
100%
Net margin
-299.9%
Precision Biosciences's revenue has increased by 41% YoY and by 39% from the previous quarter
Precision Biosciences's gross profit has increased by 41% YoY and by 39% from the previous quarter
The operating margin is up by 34% since the previous quarter and by 25% year-on-year
DTIL's net margin is up by 33% QoQ and by 19% YoY

Growth

What is Precision Biosciences's growth rate over time

Valuation

What is Precision Biosciences stock price valuation
P/E
N/A
P/B
9.1
P/S
15.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.59
DTIL's EPS is down by 13% year-on-year but it is up by 9% since the previous quarter
The company's equity fell by 49% YoY but it rose by 32% QoQ
DTIL's P/B is 21% above its last 4 quarters average of 7.5
Precision Biosciences's revenue has increased by 41% YoY and by 39% from the previous quarter
The P/S is 12% lower than the last 4 quarters average of 18.0

Efficiency

How efficient is Precision Biosciences business performance
Precision Biosciences's return on equity has shrunk by 165% YoY and by 13% QoQ
Precision Biosciences's ROA has decreased by 47% YoY but it has increased by 13% from the previous quarter
The return on invested capital has declined by 41% year-on-year and by 21% since the previous quarter
DTIL's ROS is up by 33% since the previous quarter and by 19% year-on-year

Dividends

What is DTIL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DTIL.

Financial health

How did Precision Biosciences financials performed over time
Precision Biosciences's total assets is 29% more than its total liabilities
The total liabilities has soared by 105% year-on-year and by 92% since the previous quarter
Precision Biosciences's total assets has soared by 75% from the previous quarter and by 22% YoY
DTIL's debt is 83% lower than its equity
The debt to equity has surged by 70% year-on-year but it has declined by 29% since the previous quarter
The company's equity fell by 49% YoY but it rose by 32% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.